ArticleExperimental and therapeutic medicine2014

Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients.

Li-Na Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.